TOTAL POWER OF HEART RATE VARIABILITY AND CLINICAL EFFECIANCY OF AMLODIPIN IN ADVANCED PATIENTS WITH ARTERIAL HYPERTENSION

  • L.V. Аnufrieva
  • M.I. Yabluchansky
  • О.Yu. Bychkova
Keywords: arterial hypertension, calcium channel blockers, heart rate variability, total power of heart rate spectrum, quality of life

Abstract

Twenty patients (average age 63,25±5,4 years) with arterial hypertension I-III stage were outclinic observed. Estimated parameters were levels systolic and diastolic blood pressure, frequency of heart beats, general index of quality of life (GIQL) and parameters of a spectral analysis heart rate variability (HRV) before treatment, on a background of therapy and in acute pharmacological test (APT) with amlodipin. Depending on reaction of total power (ТР) of a spectrum HRV in APT all patients were divided into 2 groups: with positive and negative reaction ТР. Irrespective of a type of reaction ТР HRV in APT and on a background of therapy at all patients were marked authentic rising GIQL and high clinical efficiency amlodipin. The most expressed and the early hypotensive effect were marked in group of the patients with negative reaction ТР HRV.

Downloads

Download data is not yet available.

References

1. Pahor M., Psaty B.M., Alderman M.N. et al. // Lancet. 2000. Vol. 356. P. 1949-1954.

2. Сіренко Ю.М., Радченко Г.Д., та інш. // Вісник дніпропетровського університету. 2000. вып. 2. С.21-23.

3. European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertension. 2003. P. 1011-1053.

4. Преображенский Д.В., Сидоренко Б.А., Шабаева Е.Н. // Кардиология. 1998. № 2. С. 66-72.

5. Cushman WC, Ford CE, Cutler JA, et al. // J Clin Hypertens. 2002. № 4. P. 1-12.

6. Яблучанский Н.И., Мартыненко А.В, Исаева А.С. Основы практического применения неинвазив-ной технологии исследования регуляторных систем человека. Харьков: «Основа». 2000. 87 с.

7. Lindholm L.H., Hansson L. // Blood Press. 1996. Vol.5. P.300-304.

8. Коркушко О.В., Саркисов К.Г., Забияка Л.К. и др. // Укр. кардіол. журн. 2001. №4. С. 43-48.

9. CAMELOT: Comparison of amlodipin versus enalapril to limit occurrences of thrombosis. Data on file. -N.Y.: Pfizer Inc. 1999. 386 p.

10. Arteaga W., Windle J.// Archives of Internal Medicine. 1995. №.155. Р. 2086-2091.

11. Standards of measurment, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, (Membership of the Task Forcelisted in the Appendix) // Eur Heart J. 1996. № 17. P. 354-381.
How to Cite
АnufrievaL., Yabluchansky, M., & BychkovaО. (1). TOTAL POWER OF HEART RATE VARIABILITY AND CLINICAL EFFECIANCY OF AMLODIPIN IN ADVANCED PATIENTS WITH ARTERIAL HYPERTENSION. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (6), 36-41. Retrieved from https://periodicals.karazin.ua/medicine/article/view/7294
Issue
No. 6 (2003)
Section
Clinical research

The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.